Trial of PRO1160 (GEN1160) in Relapsed or Refractory Non-Hodgkin Lymphoma (NHL) (PRO1160-001)
Genmab
Genmab
Novartis
Incyte Corporation
Incyte Corporation
Telix Pharmaceuticals (Innovations) Pty Limited
RAPT Therapeutics, Inc.
Inhibrx Biosciences, Inc
Xencor, Inc.
Xencor, Inc.
Xencor, Inc.
CytoMed Therapeutics Pte Ltd